Skip to content
About
About Us
Team & Board
Generic Medicines
Our Members
Advocacy & Policy
Overview
Federal Advocacy
State Advocacy
Tariff & Trade
Biosimilars
GDUFA/BsUFA User Fees
IP & Patent Reform
Inflation Reduction Act
Medicaid Generics Penalty
Resources
Resource Center
Generic & Biosimilar
Medicines Savings Report
Advocacy Priorities
Biosimilars
Events
All Events
GRx+Biosims 2026
Access! 2027
About
About Us
Team & Board
Generic Medicines
Our Members
Advocacy & Policy
Overview
Federal Advocacy
State Advocacy
Tariff & Trade
Biosimilars
GDUFA/BsUFA User Fees
IP & Patent Reform
Inflation Reduction Act
Medicaid Generics Penalty
Resources
Resource Center
Generic & Biosimilar
Medicines Savings Report
Advocacy Priorities
Biosimilars
Events
All Events
GRx+Biosims 2026
Access! 2027
JOIN
SEARCH
Home
Blog
Biosimilars Council Press Releases
Blog
Blog
February 5, 2021
AAM
Cancer Costs and Options for Care in the United States
Blog
February 4, 2021
AAM
While We Await the Vaccine, We Can Trust in Generic Drugs
Blog
January 29, 2021
AAM
AAM’s Recommendations to #SecureOurMeds
Blog
January 6, 2021
AAM
2021 Generics and Biosimilars Outlook
Blog
January 4, 2021
Founders Series
Thank you, Jean Hoffman
Blog
December 17, 2020
AAM
GRx+Biosims 2020 Recap: A Virtual Success
Blog
December 17, 2020
AAM
Helen Knows She Can Rely on Biosimilars
Blog
December 4, 2020
AAM
Member Spotlight: Associate Member CMMB’s Global Health Mission
Blog
November 25, 2020
AAM
Health Care Savings, State by State
Blog
November 2, 2020
AAM
Member Spotlight: Sandoz
Blog
October 29, 2020
AAM
Top 10 Ways to Commemorate 10 Years of Biosimilars in the U.S.
Blog
October 23, 2020
Founders Series
Thank you, Mike Puskar
Load More
Resources
2025 Savings Report
2025 Advocacy Priorities
2025 First Generics White Paper
Drug Shortages White Paper
Biosimilars Patient Resource Center
Biosimilar Research & Studies
Blog
Founders Blogs
Amicus Briefs
Patient Stories
About the Association
Generic Quality
About AAM
Our Team
Our Members
Generic Medicines
Biosimilars Council
Meet Our Board
Community Commitment
Careers
Contact Us
Advocacy & Policy
Federal Advocacy
Biosimilars
GDUFA/BsUFA User Fees
Inflation Reduction Act
Intellectual Property & Patent Reform
Medicaid Generics Penalty
State Advocacy
Tariffs & Trade
Events
Access! 2026
GRx+Biosims 2026
Press Releases
JOIN
About
About Us
Team & Board
Generic Medicines
Our Members
Advocacy & Policy
Overview
Federal Advocacy
State Advocacy
Tariff & Trade
Biosimilars
GDUFA/BsUFA User Fees
IP & Patent Reform
Inflation Reduction Act
Medicaid Generics Penalty
Resources
Resource Center
Generic & Biosimilar
Medicines Savings Report
Advocacy Priorities
Biosimilars
Events
All Events
GRx+Biosims 2026
Access! 2027
JOIN
SEARCH
